Information Journal Paper
APA:
Copy. (2017). The Recombinant Bacille Calmette-Guerin vaccine VPM1002: Ready for clinical efficacy testing. FRONTIERS IN IMMUNOLOGY, 8(-), 0-0. SID. https://sid.ir/paper/758176/en
Vancouver:
Copy. The Recombinant Bacille Calmette-Guerin vaccine VPM1002: Ready for clinical efficacy testing. FRONTIERS IN IMMUNOLOGY[Internet]. 2017;8(-):0-0. Available from: https://sid.ir/paper/758176/en
IEEE:
Copy, “The Recombinant Bacille Calmette-Guerin vaccine VPM1002: Ready for clinical efficacy testing,” FRONTIERS IN IMMUNOLOGY, vol. 8, no. -, pp. 0–0, 2017, [Online]. Available: https://sid.ir/paper/758176/en